SynerGene Therapeutics, Inc. — Form D
SynerGene Therapeutics, Inc. of POTOMAC, MD, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-16. The offering totals $7.2M, of which $6.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-12-16
- Form: D
- Accession: 0001091006-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.2M
- Amount sold: $6.4M
- Remaining: $781K
- Minimum investment: $33K
- Investors: 10
- Date of first sale: 2014-12-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-230200
Issuer
- Name: SynerGene Therapeutics, Inc.
- CIK: 0001091006
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9812 FALLS ROAD, POTOMAC, MD, 20854
- Phone: 301-299-3224
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Samuel Chang | Director | Potomac, MD |
| James Hsu | Director | Potomac, MD |
| Maria Magdalena Ruiz | Executive Officer | POTOMAC, MD |
| Raj Shah | Director | Burlingame, CA |
| Maria Malena Ruiz | Executive Officer | Potomac, MD |
Other filings by this issuer (5)
More